Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

AIMS: Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation. Despite the fact that DT is frequently used...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Schueler, Stephan, Silvestry, Scott C., Cotts, William G., Slaughter, Mark S., Levy, Wayne C., Cheng, Richard K., Beckman, Jennifer A., Villinger, Jonas, Ismyrloglou, Eleni, Tsintzos, Stelios I., Mahr, Claudius
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318455/
https://ncbi.nlm.nih.gov/pubmed/34047072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13401
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados